Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavie Moreau

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Orphanet Journal of Rare Diseases|May 11, 2015
Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnairesAntoine Regnault, Alberto Burlina, Amy Cunningham, et al.
Drug Discovery Today|April 7, 2020
Translational strategies in drug development for knee osteoarthritisKyra J Cowan, Kerstin Kleinschmidt-Dörr, Anne Gigout, et al.
Orphanet Journal of Rare Diseases|June 19, 2015
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countriesAnnet M Bosch, Alberto Burlina, Amy Cunningham, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ MiceVincent Le Moigne, Clément Raynaud, Flavie Moreau, et al.
Cellular Microbiology|September 14, 2013
Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactionsCharlotte Passemar, Ainhoa Arbués, Wladimir Malaga, et al.
Lupus Science & Medicine|October 24, 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib studyTorsten Witte, Ruth Fernandez-Ruiz, Nadezda Abramova, et al.
JIMD Reports|March 31, 2015
The Kuvan(®) Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to SapropterinFriedrich K Trefz, Ania C Muntau, Florian B Lagler, et al.
Seminars in Arthritis and Rheumatism|March 22, 2021
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trialHans Guehring, Flavie Moreau, Benjamin Daelken, et al.
Seminars in Arthritis and Rheumatism|May 19, 2021
Response letter to the EditorPhilip G Conaghan, Hans Guehring, Flavie Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulatorJesús Gonzalo-Asensio, Wladimir Malaga, Alexandre Pawlik, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Orphanet Journal of Rare Diseases|May 11, 2015
Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnairesAntoine Regnault, Alberto Burlina, Amy Cunningham, et al.
Drug Discovery Today|April 7, 2020
Translational strategies in drug development for knee osteoarthritisKyra J Cowan, Kerstin Kleinschmidt-Dörr, Anne Gigout, et al.
Orphanet Journal of Rare Diseases|June 19, 2015
Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countriesAnnet M Bosch, Alberto Burlina, Amy Cunningham, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2020
Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ MiceVincent Le Moigne, Clément Raynaud, Flavie Moreau, et al.
Cellular Microbiology|September 14, 2013
Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactionsCharlotte Passemar, Ainhoa Arbués, Wladimir Malaga, et al.
Lupus Science & Medicine|October 24, 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib studyTorsten Witte, Ruth Fernandez-Ruiz, Nadezda Abramova, et al.
JIMD Reports|March 31, 2015
The Kuvan(®) Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to SapropterinFriedrich K Trefz, Ania C Muntau, Florian B Lagler, et al.
Seminars in Arthritis and Rheumatism|March 22, 2021
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trialHans Guehring, Flavie Moreau, Benjamin Daelken, et al.
Seminars in Arthritis and Rheumatism|May 19, 2021
Response letter to the EditorPhilip G Conaghan, Hans Guehring, Flavie Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulatorJesús Gonzalo-Asensio, Wladimir Malaga, Alexandre Pawlik, et al.
Pageof 3